Pfizer Inc., the world’s largest drug maker, said New York Atty. Gen. Eliot Spitzer requested information about the promotion of some of its drugs for unapproved uses.
Pfizer said Connecticut Atty. Gen. Richard Blumenthal also requested materials on so-called off-label promotion of its Zoloft antidepressant. The company disclosed the probes in a regulatory filing.
Doctors sometimes prescribe medications for applications that haven’t been approved by regulators. Although such use is legal, promotion of drugs for off-label use isn’t.
Shares of Pfizer declined 27 cents to $28.79 on the NYSE.